The filing is an advance notice of intent to sell; the actual sale may or may not occur. Monitor subsequent Form 4 filings to confirm execution and assess whether this is part of a broader insider selling pattern. The sale size is modest relative to market cap and does not suggest a material change in the company's outlook.
IRON drugs
IRON drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 11 $87.08entry
- T+1 · 5d ago −4.42%α −4.07% · $83.23
- T+3 · todayOpen
- T+5 · tomorrow Pending
- T+20 · in 23d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
William Savage, an officer of Disc Medicine, filed a Form 144 notice of intent to sell 16,035 shares of common stock, with an estimated aggregate market value of approximately $1.30 million based on a filing date of November 10, 2026. The shares were acquired through previously exercised options on June 27, 2025, and the sale is planned for the open market via Morgan Stanley. This is a routine insider sale of a moderate size relative to the company's $3.6 billion market cap, representing about 0.04% of shares outstanding, and does not signal a change in fundamentals.
Key Facts
- Reporting person: William Savage, an officer of Disc Medicine
- Shares to be sold: 16,035 shares of common stock
- Estimated aggregate market value: $1,303,004.10
- Shares acquired on June 27, 2025 via previously exercised options for cash
- Broker: Morgan Stanley Smith Barney LLC
- Sale intended on or after November 10, 2026 on Nasdaq
- Market cap of Disc Medicine: $3.6 billion
Financial Impact
Sale of 16,035 shares valued at ~$1.3 million, representing approximately 0.04% of market cap
Risk Factors
- Insider sale could signal reduced conviction if followed by additional filings from other officers or directors
- Form 144 is only an intent to sell; the sale may not be executed
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010933 |
| Document: 0001950047-26-010933-index.html | 0001950047-26-010933 |
| Document: 0001950047-26-010933.txt | 0001950047-26-010933 |
Track record
43 reports on IRON
7 of 10 bullish or bearish reports moved the stock their way by T+20. Best: +20.07% at T+20 after the Sep 3, 2026 report. 11 of 16 went positive at some point.
Filters
- Nov 10, 20266d ago 144 Neutral 2/10 Viewing Entry $87.08 Now $76.59 −12.05% settles Dec 10
- Nov 5, 202611d ago 424B5 Bearish 5/10 Entry $78.91 Now $76.59 +2.94% settles Dec 7
- Nov 5, 202611d ago 8-K Neutral 5/10 No price data
- Nov 5, 202611d ago Press Release Bullish 7/10 Entry $78.47 Now $76.59 −2.40% settles Dec 4
- Nov 4, 202612d ago Press Release Neutral 3/10 Entry $83.28 Now $76.59 −8.03% settles Dec 3
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $81.16 Now $76.59 −5.63% settles Dec 2
- Oct 26, 202621d ago SC 13D/A Neutral 3/10 Entry $79.90 Now $76.59 −4.14% settles Nov 24
- Oct 22, 202625d ago 8-K Bearish 6/10 Entry $74.51 Now $76.59 −2.79% settles Nov 20
- Oct 21, 202626d ago 424B5 Bearish 6/10 Entry $75.03 Now $76.59 −2.08% settles Nov 19
- Oct 21, 202626d ago 144 Neutral 2/10 Entry $75.03 Now $76.59 +2.08% settles Nov 19
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers